Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers.
Raluca B DumitruLesley-Anne BissellBara ErhayiemAnanth KidambiAna-Maria H DumitruGraham FentGiuseppina AbignanoHelena DonicaAgata BurskaJohn P GreenwoodJohn BiglandsDominik SchlosshanFrancesco Del GaldoSven PleinMaya H BuchPublished in: RMD open (2021)
These data indicate standard serum cardiac biomarkers (notably NT-proBNP) and CMR indices of myocardial fibrosis associate with adverse CV outcomes in SSc. This forms the basis to develop a prognostic model in larger, longitudinal studies.
Keyphrases
- systemic sclerosis
- left ventricular
- interstitial lung disease
- magnetic resonance imaging
- electronic health record
- heart failure
- cross sectional
- big data
- type diabetes
- emergency department
- magnetic resonance
- adipose tissue
- diffusion weighted imaging
- metabolic syndrome
- atrial fibrillation
- case control
- skeletal muscle
- idiopathic pulmonary fibrosis